 | • レポートコード：QYR2104Z4970 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、再生医療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞治療、組織工学、生体材料、その他）、用途別市場規模（皮膚科、心臓血管、中枢神経系、整形外科、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・再生医療の市場動向 ・企業の競争状況、市場シェア ・再生医療の種類別市場規模（細胞治療、組織工学、生体材料、その他） ・再生医療の用途別市場規模（皮膚科、心臓血管、中枢神経系、整形外科、その他） ・再生医療の北米市場規模2016-2027（アメリカ、カナダ） ・再生医療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・再生医療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・再生医療の中南米市場規模2016-2027（メキシコ、ブラジル） ・再生医療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（DePuy Synthes、Medtronic、ZimmerBiomet、Stryker、Acelity、MiMedx Group、Organogenesis、UniQure、Cellular Dynamics International、Osiris Therapeutics、Vcanbio、Gamida Cell、Golden Meditech、Cytori、Celgene、Vericel Corporation、Guanhao Biotech、Mesoblast、Stemcell Technologies、Bellicum Pharmaceuticals） ・結論 |
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the “process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function”. It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Currently, some companies in the world can provide regenerative medicine service, mainly concentrating in USA. The main market players are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, etc.
USA is the largest market of regenerative medicine, which occupies 51.09 percent of global regenerative medicine market share in 2015. It is followed by EU, which has around 16.66 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
According to the research, the most potential market in the main countries of regenerative medicine industry is Asia, determined by the rising level of medical care. Besides, South America, Middle East should also be focused by the investors. They are the potential consumers of regenerative medicine.
Despite the presence of competition problems, due to the huge industry profits, investors are still optimistic about this area; there will be more investments to enter the field.
The relatively-mature technology is cell transplantation; tissue engineering and therapeutic cloning has its technical advantages, which is the direction of future research and development.
Market Analysis and Insights: Global Regenerative Medicine Market
The global Regenerative Medicine market size is projected to reach US$ 36710 million by 2026, from US$ 8298.8 million in 2019, at a CAGR of 23.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Regenerative Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Regenerative Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Regenerative Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Regenerative Medicine market.
Global Regenerative Medicine Scope and Market Size
Regenerative Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cell Therapy
Tissue Engineering
Biomaterial
Other
Segment by Application
Dermatology
Cardiovascular
CNS
Orthopedic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Stryker
Acelity
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2016-2027)
2.2 Regenerative Medicine Growth Trends by Regions
2.2.1 Regenerative Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Regenerative Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Regenerative Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Regenerative Medicine Industry Dynamic
2.3.1 Regenerative Medicine Market Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Medicine Players by Revenue
3.1.1 Global Top Regenerative Medicine Players by Revenue (2016-2021)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Regenerative Medicine Revenue
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2020
3.5 Regenerative Medicine Key Players Head office and Area Served
3.6 Key Players Regenerative Medicine Product Solution and Service
3.7 Date of Enter into Regenerative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2016-2021)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2022-2027)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2016-2021)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Regenerative Medicine Market Size (2016-2027)
6.2 North America Regenerative Medicine Market Size by Type
6.2.1 North America Regenerative Medicine Market Size by Type (2016-2021)
6.2.2 North America Regenerative Medicine Market Size by Type (2022-2027)
6.2.3 North America Regenerative Medicine Market Size by Type (2016-2027)
6.3 North America Regenerative Medicine Market Size by Application
6.3.1 North America Regenerative Medicine Market Size by Application (2016-2021)
6.3.2 North America Regenerative Medicine Market Size by Application (2022-2027)
6.3.3 North America Regenerative Medicine Market Size by Application (2016-2027)
6.4 North America Regenerative Medicine Market Size by Country
6.4.1 North America Regenerative Medicine Market Size by Country (2016-2021)
6.4.2 North America Regenerative Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2016-2027)
7.2 Europe Regenerative Medicine Market Size by Type
7.2.1 Europe Regenerative Medicine Market Size by Type (2016-2021)
7.2.2 Europe Regenerative Medicine Market Size by Type (2022-2027)
7.2.3 Europe Regenerative Medicine Market Size by Type (2016-2027)
7.3 Europe Regenerative Medicine Market Size by Application
7.3.1 Europe Regenerative Medicine Market Size by Application (2016-2021)
7.3.2 Europe Regenerative Medicine Market Size by Application (2022-2027)
7.3.3 Europe Regenerative Medicine Market Size by Application (2016-2027)
7.4 Europe Regenerative Medicine Market Size by Country
7.4.1 Europe Regenerative Medicine Market Size by Country (2016-2021)
7.4.2 Europe Regenerative Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Market Size (2016-2027)
8.2 Asia-Pacific Regenerative Medicine Market Size by Type
8.2.1 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Regenerative Medicine Market Size by Application
8.3.1 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Regenerative Medicine Market Size by Region
8.4.1 Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Regenerative Medicine Market Size (2016-2027)
9.2 Latin America Regenerative Medicine Market Size by Type
9.2.1 Latin America Regenerative Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Regenerative Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Regenerative Medicine Market Size by Type (2016-2027)
9.3 Latin America Regenerative Medicine Market Size by Application
9.3.1 Latin America Regenerative Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Regenerative Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Regenerative Medicine Market Size by Application (2016-2027)
9.4 Latin America Regenerative Medicine Market Size by Country
9.4.1 Latin America Regenerative Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Regenerative Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine Market Size (2016-2027)
10.2 Middle East & Africa Regenerative Medicine Market Size by Type
10.2.1 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Regenerative Medicine Market Size by Application
10.3.1 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Regenerative Medicine Market Size by Country
10.4.1 Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 DePuy Synthes
11.1.1 DePuy Synthes Company Details
11.1.2 DePuy Synthes Business Overview
11.1.3 DePuy Synthes Regenerative Medicine Introduction
11.1.4 DePuy Synthes Revenue in Regenerative Medicine Business (2016-2021)
11.1.5 DePuy Synthes Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 ZimmerBiomet
11.3.1 ZimmerBiomet Company Details
11.3.2 ZimmerBiomet Business Overview
11.3.3 ZimmerBiomet Regenerative Medicine Introduction
11.3.4 ZimmerBiomet Revenue in Regenerative Medicine Business (2016-2021)
11.3.5 ZimmerBiomet Recent Development
11.4 Stryker
11.4.1 Stryker Company Details
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2016-2021)
11.4.5 Stryker Recent Development
11.5 Acelity
11.5.1 Acelity Company Details
11.5.2 Acelity Business Overview
11.5.3 Acelity Regenerative Medicine Introduction
11.5.4 Acelity Revenue in Regenerative Medicine Business (2016-2021)
11.5.5 Acelity Recent Development
11.6 MiMedx Group
11.6.1 MiMedx Group Company Details
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2016-2021)
11.6.5 MiMedx Group Recent Development
11.7 Organogenesis
11.7.1 Organogenesis Company Details
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2016-2021)
11.7.5 Organogenesis Recent Development
11.8 UniQure
11.8.1 UniQure Company Details
11.8.2 UniQure Business Overview
11.8.3 UniQure Regenerative Medicine Introduction
11.8.4 UniQure Revenue in Regenerative Medicine Business (2016-2021)
11.8.5 UniQure Recent Development
11.9 Cellular Dynamics International
11.9.1 Cellular Dynamics International Company Details
11.9.2 Cellular Dynamics International Business Overview
11.9.3 Cellular Dynamics International Regenerative Medicine Introduction
11.9.4 Cellular Dynamics International Revenue in Regenerative Medicine Business (2016-2021)
11.9.5 Cellular Dynamics International Recent Development
11.10 Osiris Therapeutics
11.10.1 Osiris Therapeutics Company Details
11.10.2 Osiris Therapeutics Business Overview
11.10.3 Osiris Therapeutics Regenerative Medicine Introduction
11.10.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021)
11.10.5 Osiris Therapeutics Recent Development
11.11 Vcanbio
11.11.1 Vcanbio Company Details
11.11.2 Vcanbio Business Overview
11.11.3 Vcanbio Regenerative Medicine Introduction
11.11.4 Vcanbio Revenue in Regenerative Medicine Business (2016-2021)
11.11.5 Vcanbio Recent Development
11.12 Gamida Cell
11.12.1 Gamida Cell Company Details
11.12.2 Gamida Cell Business Overview
11.12.3 Gamida Cell Regenerative Medicine Introduction
11.12.4 Gamida Cell Revenue in Regenerative Medicine Business (2016-2021)
11.12.5 Gamida Cell Recent Development
11.13 Golden Meditech
11.13.1 Golden Meditech Company Details
11.13.2 Golden Meditech Business Overview
11.13.3 Golden Meditech Regenerative Medicine Introduction
11.13.4 Golden Meditech Revenue in Regenerative Medicine Business (2016-2021)
11.13.5 Golden Meditech Recent Development
11.14 Cytori
11.14.1 Cytori Company Details
11.14.2 Cytori Business Overview
11.14.3 Cytori Regenerative Medicine Introduction
11.14.4 Cytori Revenue in Regenerative Medicine Business (2016-2021)
11.14.5 Cytori Recent Development
11.15 Celgene
11.15.1 Celgene Company Details
11.15.2 Celgene Business Overview
11.15.3 Celgene Regenerative Medicine Introduction
11.15.4 Celgene Revenue in Regenerative Medicine Business (2016-2021)
11.15.5 Celgene Recent Development
11.16 Vericel Corporation
11.16.1 Vericel Corporation Company Details
11.16.2 Vericel Corporation Business Overview
11.16.3 Vericel Corporation Regenerative Medicine Introduction
11.16.4 Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021)
11.16.5 Vericel Corporation Recent Development
11.17 Guanhao Biotech
11.17.1 Guanhao Biotech Company Details
11.17.2 Guanhao Biotech Business Overview
11.17.3 Guanhao Biotech Regenerative Medicine Introduction
11.17.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021)
11.17.5 Guanhao Biotech Recent Development
11.18 Mesoblast
11.18.1 Mesoblast Company Details
11.18.2 Mesoblast Business Overview
11.18.3 Mesoblast Regenerative Medicine Introduction
11.18.4 Mesoblast Revenue in Regenerative Medicine Business (2016-2021)
11.18.5 Mesoblast Recent Development
11.18 Stemcell Technologies
.1 Stemcell Technologies Company Details
.2 Stemcell Technologies Business Overview
.3 Stemcell Technologies Regenerative Medicine Introduction
.4 Stemcell Technologies Revenue in Regenerative Medicine Business (2016-2021)
.5 Stemcell Technologies Recent Development
11.20 Bellicum Pharmaceuticals
11.20.1 Bellicum Pharmaceuticals Company Details
11.20.2 Bellicum Pharmaceuticals Business Overview
11.20.3 Bellicum Pharmaceuticals Regenerative Medicine Introduction
11.20.4 Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2016-2021)
11.20.5 Bellicum Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Key Players of Biomaterial
Table 5. Key Players of Other
Table 6. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Regenerative Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Regenerative Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Regenerative Medicine Market Share by Regions (2016-2021)
Table 10. Global Regenerative Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Regenerative Medicine Market Share by Regions (2022-2027)
Table 12. Regenerative Medicine Market Trends
Table 13. Regenerative Medicine Market Drivers
Table 14. Regenerative Medicine Market Challenges
Table 15. Regenerative Medicine Market Restraints
Table 16. Global Regenerative Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Regenerative Medicine Market Share by Players (2016-2021)
Table 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020)
Table 19. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Regenerative Medicine Product Solution and Service
Table 23. Date of Enter into Regenerative Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Regenerative Medicine Revenue Market Share by Type (2016-2021)
Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Regenerative Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Regenerative Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Regenerative Medicine Revenue Market Share by Application (2016-2021)
Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Regenerative Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 63. DePuy Synthes Company Details
Table 64. DePuy Synthes Business Overview
Table 65. DePuy Synthes Regenerative Medicine Product
Table 66. DePuy Synthes Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 67. DePuy Synthes Recent Development
Table 68. Medtronic Company Details
Table 69. Medtronic Business Overview
Table 70. Medtronic Regenerative Medicine Product
Table 71. Medtronic Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 72. Medtronic Recent Development
Table 73. ZimmerBiomet Company Details
Table 74. ZimmerBiomet Business Overview
Table 75. ZimmerBiomet Regenerative Medicine Product
Table 76. ZimmerBiomet Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 77. ZimmerBiomet Recent Development
Table 78. Stryker Company Details
Table 79. Stryker Business Overview
Table 80. Stryker Regenerative Medicine Product
Table 81. Stryker Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 82. Stryker Recent Development
Table 83. Acelity Company Details
Table 84. Acelity Business Overview
Table 85. Acelity Regenerative Medicine Product
Table 86. Acelity Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 87. Acelity Recent Development
Table 88. MiMedx Group Company Details
Table 89. MiMedx Group Business Overview
Table 90. MiMedx Group Regenerative Medicine Product
Table 91. MiMedx Group Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 92. MiMedx Group Recent Development
Table 93. Organogenesis Company Details
Table 94. Organogenesis Business Overview
Table 95. Organogenesis Regenerative Medicine Product
Table 96. Organogenesis Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 97. Organogenesis Recent Development
Table 98. UniQure Company Details
Table 99. UniQure Business Overview
Table 100. UniQure Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 101. UniQure Recent Development
Table 102. Cellular Dynamics International Company Details
Table 103. Cellular Dynamics International Business Overview
Table 104. Cellular Dynamics International Regenerative Medicine Product
Table 105. Cellular Dynamics International Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 106. Cellular Dynamics International Recent Development
Table 107. Osiris Therapeutics Company Details
Table 108. Osiris Therapeutics Business Overview
Table 109. Osiris Therapeutics Regenerative Medicine Product
Table 110. Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 111. Osiris Therapeutics Recent Development
Table 112. Vcanbio Company Details
Table 113. Vcanbio Business Overview
Table 114. Vcanbio Regenerative Medicine Product
Table 115. Vcanbio Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 116. Vcanbio Recent Development
Table 117. Gamida Cell Company Details
Table 118. Gamida Cell Business Overview
Table 119. Gamida Cell Regenerative Medicine Product
Table 120. Gamida Cell Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 121. Gamida Cell Recent Development
Table 122. Golden Meditech Company Details
Table 123. Golden Meditech Business Overview
Table 124. Golden Meditech Regenerative Medicine Product
Table 125. Golden Meditech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 126. Golden Meditech Recent Development
Table 127. Cytori Company Details
Table 128. Cytori Business Overview
Table 129. Cytori Regenerative Medicine Product
Table 130. Cytori Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 131. Cytori Recent Development
Table 132. Celgene Company Details
Table 133. Celgene Business Overview
Table 134. Celgene Regenerative Medicine Product
Table 135. Celgene Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 136. Celgene Recent Development
Table 137. Vericel Corporation Company Details
Table 138. Vericel Corporation Business Overview
Table 139. Vericel Corporation Regenerative Medicine Product
Table 140. Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 141. Vericel Corporation Recent Development
Table 142. Guanhao Biotech Company Details
Table 143. Guanhao Biotech Business Overview
Table 144. Guanhao Biotech Regenerative Medicine Product
Table 145. Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 146. Guanhao Biotech Recent Development
Table 147. Mesoblast Company Details
Table 148. Mesoblast Business Overview
Table 149. Mesoblast Regenerative Medicine Product
Table 150. Mesoblast Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 151. Mesoblast Recent Development
Table 152. Stemcell Technologies Company Details
Table 153. Stemcell Technologies Business Overview
Table 154. Stemcell Technologies Regenerative Medicine Product
Table 155. Stemcell Technologies Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 156. Stemcell Technologies Recent Development
Table 157. Bellicum Pharmaceuticals Company Details
Table 158. Bellicum Pharmaceuticals Business Overview
Table 159. Bellicum Pharmaceuticals Regenerative Medicine Product
Table 160. Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 161. Bellicum Pharmaceuticals Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Medicine Market Share by Type: 2020 VS 2027
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Biomaterial Features
Figure 5. Other Features
Figure 6. Global Regenerative Medicine Market Share by Application: 2020 VS 2027
Figure 7. Dermatology Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. CNS Case Studies
Figure 10. Orthopedic Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Medicine Report Years Considered
Figure 13. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Regenerative Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Regenerative Medicine Market Share by Regions: 2020 VS 2027
Figure 16. Global Regenerative Medicine Market Share by Regions (2022-2027)
Figure 17. Global Regenerative Medicine Market Share by Players in 2020
Figure 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2020
Figure 20. Global Regenerative Medicine Revenue Market Share by Type (2016-2021)
Figure 21. Global Regenerative Medicine Revenue Market Share by Type (2022-2027)
Figure 22. North America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Regenerative Medicine Market Share by Type (2016-2027)
Figure 24. North America Regenerative Medicine Market Share by Application (2016-2027)
Figure 25. North America Regenerative Medicine Market Share by Country (2016-2027)
Figure 26. United States Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Regenerative Medicine Market Share by Type (2016-2027)
Figure 30. Europe Regenerative Medicine Market Share by Application (2016-2027)
Figure 31. Europe Regenerative Medicine Market Share by Country (2016-2027)
Figure 32. Germany Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Regenerative Medicine Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Regenerative Medicine Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Regenerative Medicine Market Share by Region (2016-2027)
Figure 42. China Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Regenerative Medicine Market Share by Type (2016-2027)
Figure 50. Latin America Regenerative Medicine Market Share by Application (2016-2027)
Figure 51. Latin America Regenerative Medicine Market Share by Country (2016-2027)
Figure 52. Mexico Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Regenerative Medicine Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Regenerative Medicine Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Regenerative Medicine Market Share by Country (2016-2027)
Figure 58. Turkey Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. DePuy Synthes Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 62. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 63. ZimmerBiomet Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 64. Stryker Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 65. Acelity Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 66. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 67. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 68. UniQure Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 69. Cellular Dynamics International Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 70. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 71. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 72. Gamida Cell Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 73. Golden Meditech Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 74. Cytori Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 75. Celgene Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 76. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 77. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 78. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 79. Stemcell Technologies Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 80. Bellicum Pharmaceuticals Revenue Growth Rate in Regenerative Medicine Business (2016-2021)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
世界の整形外科軟部組織修復＆スポーツ医療市場規模・現状・予測（2021年-2027年） Orthopedic soft tissue repair consists of devices, which are used for fixing rotator cuff, shoulder labrum, ACL/PCL, meniscal repair, graft options for tendons and cartilage along with devices for hip arthroscopy. These devices are used for closed technique treatments of injured or worn joints. Majo…- 世界の再生医療市場規模・現状・予測（2021年-2027年） Regeneration is renewal through the internal processes of a body or system. Something which embodies this action can be described as regenerative. The global market study on regenerative therapies is expected to grow rapidly owing to its wide applications in orthopedic, cardiovascular and soft tissu…
- 世界の変形性関節症用再生療法市場規模・現状・予測（2021年-2027年） Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market. Market Analysis and Insights: Global Regenerative Therapies for Osteoart…
- 世界の整形軟部組織修復・スポーツ医療市場 2021：企業別、地域別、種類・用途別 The Orthopedic Soft Tissue Repair and Sports Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 再生医療の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Regenerative Medicine from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 2015 to…